EPHA2 and melanoma: Alternatively, another exosome-derived candidate for chemoresistance transfer was identified, ephrin type-A receptor 2 (EphA2), described above in transfer of metastatic potential via EVs, which is a receptor tyrosine kinase also found commonly upregulated and responsible for therapy resistance in several other cancers such as breast, cervical and melanoma.